ATE288255T1 - Polares bukkales spray - Google Patents

Polares bukkales spray

Info

Publication number
ATE288255T1
ATE288255T1 AT97914779T AT97914779T ATE288255T1 AT E288255 T1 ATE288255 T1 AT E288255T1 AT 97914779 T AT97914779 T AT 97914779T AT 97914779 T AT97914779 T AT 97914779T AT E288255 T1 ATE288255 T1 AT E288255T1
Authority
AT
Austria
Prior art keywords
polar solvent
polar
invention comprises
flavoring agent
aerosol spray
Prior art date
Application number
AT97914779T
Other languages
English (en)
Inventor
Harry A Dugger Iii
Original Assignee
Novadel Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24525609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE288255(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novadel Pharma Inc filed Critical Novadel Pharma Inc
Application granted granted Critical
Publication of ATE288255T1 publication Critical patent/ATE288255T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97914779T 1996-04-12 1997-02-21 Polares bukkales spray ATE288255T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63006596A 1996-04-12 1996-04-12
PCT/US1997/002793 WO1997038662A2 (en) 1996-04-12 1997-02-21 Buccal polar spray or capsule

Publications (1)

Publication Number Publication Date
ATE288255T1 true ATE288255T1 (de) 2005-02-15

Family

ID=24525609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97914779T ATE288255T1 (de) 1996-04-12 1997-02-21 Polares bukkales spray

Country Status (8)

Country Link
US (1) US6110486A (de)
EP (1) EP0910339B1 (de)
AT (1) ATE288255T1 (de)
AU (1) AU2190697A (de)
DE (1) DE69732412T2 (de)
ES (1) ES2234010T3 (de)
PT (1) PT910339E (de)
WO (1) WO1997038662A2 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
AU8107998A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
CA2306024C (en) * 1997-10-01 2011-04-26 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US7087215B2 (en) * 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
GB9911037D0 (en) * 1999-05-13 1999-07-14 Micap Limited Nicotine delivery service
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
EP1496873B2 (de) 2002-04-25 2011-08-10 Banner Pharmacaps, Inc. Kaubare weichkapsel
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
EP1444976A1 (de) * 2003-02-10 2004-08-11 Novadel Pharma Inc. Bukkale, polare und nichtpolare Spray und Kapsel
JP2006524190A (ja) * 2003-02-20 2006-10-26 テバ ファーマシューティカル インダストリーズ リミティド 薬剤のメントール溶液
US20060062812A1 (en) * 2003-03-11 2006-03-23 Calvin Ross Novel compositions
US9241902B2 (en) 2003-12-17 2016-01-26 R.P. Scherer Technologies, Llc Chewable soft capsules containing ungelatinized starch
KR20130116378A (ko) * 2004-02-17 2013-10-23 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
US7850987B2 (en) * 2004-04-08 2010-12-14 Micronutrient, Llc Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
NZ551336A (en) 2004-04-22 2010-04-30 Acucort Ab Pharmaceutical compositions for acute glucocorticoid therapy
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
ES2490595T3 (es) 2005-02-17 2014-09-04 Abbott Laboratories Administración transmucosal de composiciones de fármacos para tratar y prevenir trastornos en animales
US20060276501A1 (en) * 2005-05-25 2006-12-07 Transoral Pharmaceuticals, Inc. Solid compositions for treating middle-of-the-night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
WO2007123955A2 (en) * 2006-04-19 2007-11-01 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
ES2659316T3 (es) 2006-06-08 2018-03-14 Allergan Pharmaceuticals International Limited Procedimientos para administrar formas de dosificación sólidas de etinilestradiol y profármacos del mismo con biodisponibilidad mejorada
TW200840595A (en) * 2006-12-12 2008-10-16 Organon Nv Oral contraceptive spray
CA2673049C (en) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Stable anti-nausea oral spray formulations and methods
US20080275030A1 (en) * 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
WO2008091588A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
WO2008141264A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
JP2012517402A (ja) * 2009-02-11 2012-08-02 ヘグルンド、エー．エス． 禁煙を目的としたニコチンを頬側吸収するための組成物
WO2011064316A2 (en) 2009-11-25 2011-06-03 Paolo Botti Mucosal delivery of peptides
GB2482868A (en) * 2010-08-16 2012-02-22 Franciscus Wilhelmus Henricus Maria Merkus A testosterone liquid spray formulation for oromucosal administration
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
EP3332787A4 (de) * 2015-09-30 2018-08-01 Fujifilm Corporation Transdermal absorbierbare zusammensetzung
US10786449B2 (en) 2017-07-17 2020-09-29 Northriver Pharm, LLC Nasal composition comprising a mucoadhesive polymer
WO2025090448A1 (en) * 2023-10-23 2025-05-01 R.P. Scherer Technologies, Llc Capsules for oral and nasal delivery of pharmaceutical products

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (de) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
SE7812207L (sv) * 1977-12-01 1979-06-02 Welsh Nat School Med Apparat, forfarande och framstellda produkter for anvendning vid administration av antihistaminer
DE3338978A1 (de) * 1982-10-29 1984-05-03 Basf Ag, 6700 Ludwigshafen Verapamil und gallopamil und ihre physiologisch vertraeglichen salze zur resorptiven anwendung auf den schleimhaeuten des mundes, des nasen-rachen-raums und des rektums
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
HU199678B (en) * 1988-07-08 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing aerosols containing nitroglicerol
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
JP3661131B2 (ja) * 1992-02-20 2005-06-15 アスペン ファーマケア ヨーロッパ リミテッド 喫煙抑制具
JPH07506839A (ja) * 1992-12-04 1995-07-27 メイヤー・ファーマシューティカル・ラボラトリース・インコーポレーテッド スプレー可能な鎮痛剤組成物およびその使用方法
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5456677A (en) * 1994-08-22 1995-10-10 Spector; John E. Method for oral spray administration of caffeine
NZ280610A (en) * 1994-12-29 1997-08-22 Mcneil Ppc Inc Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent

Also Published As

Publication number Publication date
EP0910339B1 (de) 2005-02-02
WO1997038662A2 (en) 1997-10-23
WO1997038662A3 (en) 1998-02-12
ES2234010T3 (es) 2005-06-16
EP0910339A2 (de) 1999-04-28
DE69732412T2 (de) 2006-01-05
AU2190697A (en) 1997-11-07
US6110486A (en) 2000-08-29
DE69732412D1 (de) 2005-03-10
PT910339E (pt) 2005-05-31

Similar Documents

Publication Publication Date Title
DE69732412D1 (de) Polares bukkales spray
CA2252050A1 (en) Buccal, non-polar spray or capsule
ATE237322T1 (de) Nichtpolares nitroglycerinspray zur bukkalen verabreichung
WO2002043657A3 (en) Improved pullulan free edible film compositions and methods of making the same
WO2004043428A3 (en) Buccal, polar and non-polar spray or capsule containing drugs for treating pain
DE59707812D1 (de) Opioidantagonisthaltige galenische formulierung
DK0949907T3 (da) Fremgangsmåder og præparater til forbedret biotilgængelighed og biologisk aktive midler til slimhindeadministration
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
BR9707689A (pt) Caramelos contendo um agente adoçante
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
PT1059848E (pt) Goma de mascar revestida, metodo para a sua preparacao e utilizacao de uma ou mais substancias activas sob a forma solida
CA2342340A1 (en) New sustained release oral formulations
CA2251886A1 (en) An oral pharmaceutical formulation containing ibandronate
WO2004019912A3 (en) Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer
WO2004035021A3 (en) Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
WO2004019911A3 (en) Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders
NO974194D0 (no) Forbedringer i, eller vedrörende, organiske sammensetninger
CA2377174A1 (en) Oral administration forms for administering a fixed tramadol and diclofenac combination
CA2366679A1 (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
HRP20010277B1 (hr) Farmaceutski pripravak koji sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
IT1302682B1 (it) Composizioni farmaceutiche orali contenenti buprenorfina
IT1285398B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
CA2244357A1 (en) A novel pharmaceutical composition for inhalation containing cr 2039 (andolast)
CA2252038A1 (en) Buccal polar spray or capsule

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0910339

Country of ref document: EP

RZN Patent revoked